About James Bridges
Form D filings for Minerva Biotechnologies from 2014 to 2023 list James Bridges as director.
James Bridges first appears on SEC filings in 2014.
Experience
This experience comes from SEC filings. The years are when the filings name James Bridges in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Bridges works with at each company, as listed on that company's latest Form D.
Minerva Biotechnologies Corp. · Form D, Dec 5, 2023
KK
Kenneth Kosik
Director
RS
Robert Staszewski
Director
RA
Ronald Axelrod
Director
JN
Joseph Nathan
Director
LC
Lawrence Coolidge
Director
KR
Kenneth Reed
Director
CB
Cynthia Bamdad
President & Chief Executive Officer, director